[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HU9303364D0 - Compositions containing calcium, microelements, vitamine d and other medicinal components - Google Patents

Compositions containing calcium, microelements, vitamine d and other medicinal components

Info

Publication number
HU9303364D0
HU9303364D0 HU9303364A HU9303364A HU9303364D0 HU 9303364 D0 HU9303364 D0 HU 9303364D0 HU 9303364 A HU9303364 A HU 9303364A HU 9303364 A HU9303364 A HU 9303364A HU 9303364 D0 HU9303364 D0 HU 9303364D0
Authority
HU
Hungary
Prior art keywords
vitamine
microelements
compositions containing
containing calcium
medicinal components
Prior art date
Application number
HU9303364A
Other languages
Hungarian (hu)
Other versions
HUT66379A (en
Inventor
Mark Benson Andon
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of HU9303364D0 publication Critical patent/HU9303364D0/en
Publication of HUT66379A publication Critical patent/HUT66379A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9303364A 1991-05-28 1992-05-15 Calcium, trace mineral, vitamin d and drug therapy combinations HUT66379A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70583291A 1991-05-28 1991-05-28

Publications (2)

Publication Number Publication Date
HU9303364D0 true HU9303364D0 (en) 1994-03-28
HUT66379A HUT66379A (en) 1994-11-28

Family

ID=24835140

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9303364A HUT66379A (en) 1991-05-28 1992-05-15 Calcium, trace mineral, vitamin d and drug therapy combinations

Country Status (13)

Country Link
EP (1) EP0586521A1 (en)
JP (1) JPH07502012A (en)
KR (1) KR100244603B1 (en)
AU (1) AU666654B2 (en)
BR (1) BR9206072A (en)
CA (1) CA2109958C (en)
CZ (1) CZ281823B6 (en)
HU (1) HUT66379A (en)
IE (1) IE921701A1 (en)
NO (1) NO934282L (en)
NZ (1) NZ242920A (en)
SK (1) SK132693A3 (en)
WO (1) WO1992021355A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
FR2704393B1 (en) * 1993-04-30 1995-06-02 Boiron Absorbable nutritional supplement to optimize growth and maintain strong bones.
US5763429A (en) 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
FR2723682B1 (en) * 1994-08-19 1996-09-27 Boiron ABSORBABLE NUTRITIONAL SUPPLEMENT FOR THE DAILY BALANCE OF CHILDREN AND ADOLESCENTS.
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
DE19503190A1 (en) * 1995-02-01 1996-08-08 Dietl Hans Means for influencing disorders of bone formation
US5597595A (en) * 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5609897A (en) * 1995-04-07 1997-03-11 Abbott Laboratories Powdered beverage concentrate or additive fortified with calcium and vitamin D
US5698222A (en) * 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
JP2001505188A (en) * 1996-09-26 2001-04-17 オゥクラホゥマ、メディカル、リサーチ、ファウンデイシャン Use of NL-α-aspartyl-L-phenylalanine 1-methyl ester and its derivatives for regression of disease
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
PL336231A1 (en) * 1997-02-13 2000-06-19 Bone Care International System for aimed therapeutic delivery of vitamin d compounds
GB9703109D0 (en) * 1997-02-14 1997-04-02 Smith & Nephew Compositions
US6479474B2 (en) 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
PL1622630T3 (en) * 2003-05-07 2013-01-31 Osteologix As Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions
EP1711072B1 (en) * 2004-01-28 2011-10-05 Dr. Paul Lohmann GmbH KG Method for the production of a calcium lactate malate compound and calcium lactate malate compound
US20060069069A1 (en) * 2004-07-15 2006-03-30 Nanobac Pharmaceuticals, Inc. Methods and compositions for the administration of calcium chelators, bisphosponates and/or citrate compounds and their pharmaceutical uses
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
KR20080098616A (en) * 2006-02-21 2008-11-11 뉴트리조이, 인크. Composition and preparation methods for preparing protein-containing foods or beverages with improved taste and fruit juices supplemented with calcium and trace minerals
JP5619334B2 (en) * 2006-06-14 2014-11-05 允聖 崔 Bone strengthening agent
JP4762346B2 (en) * 2006-08-17 2011-08-31 ザ プロクター アンド ギャンブル カンパニー Composition containing calcium citrate malate and method for producing the same
AU2007285387B2 (en) * 2006-08-17 2010-06-24 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
EP2185136A2 (en) * 2007-08-09 2010-05-19 Novartis Ag Oral calcitonin compositions and applications thereof
DK2473172T3 (en) 2009-09-01 2015-06-15 Univ Duke BISPHOSPHONATSAMMENSÆTNINGER and Methods for treating congestive heart failure
US9949992B2 (en) 2011-11-16 2018-04-24 Duke University Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992556A (en) * 1973-05-07 1976-11-16 Vitamins, Inc. Supplemented food product
GB8622025D0 (en) * 1986-09-12 1986-10-22 Beecham Group Plc Composition
FR2618305B1 (en) * 1987-07-23 1989-10-27 Synthelabo NUTRITIONAL MIXTURE FOR THE ELDERLY
JP2516794B2 (en) * 1988-02-26 1996-07-24 雪印乳業株式会社 Baby formula containing vitamin D metabolites
EP0343703A3 (en) * 1988-05-26 1990-06-06 The Procter & Gamble Company Mineral supplements with sugar alcohols
US5151274A (en) * 1990-08-06 1992-09-29 The Procter & Gamble Company Calcium and trace mineral supplements

Also Published As

Publication number Publication date
SK132693A3 (en) 1994-06-08
CZ281823B6 (en) 1997-02-12
NO934282D0 (en) 1993-11-26
AU1996892A (en) 1993-01-08
HUT66379A (en) 1994-11-28
CA2109958C (en) 1997-06-10
NO934282L (en) 1994-01-28
WO1992021355A1 (en) 1992-12-10
AU666654B2 (en) 1996-02-22
BR9206072A (en) 1994-11-15
KR100244603B1 (en) 2000-03-02
JPH07502012A (en) 1995-03-02
IE921701A1 (en) 1992-12-02
NZ242920A (en) 1995-06-27
CZ255393A3 (en) 1994-07-13
EP0586521A1 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
HU9303364D0 (en) Compositions containing calcium, microelements, vitamine d and other medicinal components
IL101380A0 (en) Bis-naphthalimides,their preparation and pharmaceutical compositions containing them
IL101763A0 (en) Dialkylenepiperidino compounds and their enantiomers,their preparation and pharmaceutical compositions containing them
IL101864A0 (en) Thiopyranopyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL103529A0 (en) 1,4-benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
GB9213393D0 (en) Pharmaceutical composition
GB9210974D0 (en) Pharmaceutical composition
IL102337A0 (en) Pyrrolpyrazines,their manufacture and pharmaceutical compositions containing them
IL102365A0 (en) Substituted triazolinones,their preparation and pharmaceutical compositions containing them
IL103502A0 (en) Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
AP9200356A0 (en) Pharmaceutical composition
GB9108080D0 (en) Pharmaceutical composition
GB2255017B (en) Solid product containing propolis components,and its preparation and uses
HU9303113D0 (en) Pharmaceutical compositions containing 1,2-dithiol-3-thione-derivatives
IL116190A (en) Eleutherobin, analogs thereof and pharmaceutical compositions containing them
IL110480A0 (en) Methylguanidine derivatives, their preparation and pharmaceutical compositions containing them
IL102500A0 (en) 3-deoxy-mannosamine derivatives,their preparation and pharmaceutical compositions containing them
IL104042A0 (en) Substituted diphenylsulfides,their preparation and pharmaceutical compositions containing them
GB8808758D0 (en) Nutritional and medicinal compositions
IL103926A0 (en) Quinolylmethoxyphenyl-acetamides,their preparation and pharmaceutical compositions containing them
IL102666A0 (en) Quinolin-2-yl-methoxybenzyl-hydroxyureas,their preparation and pharmaceutical compositions containing them
IL101482A0 (en) Substituted 2',3'-dideoxy-5-trifluoromethyluridines,and pharmaceutical compositions containing them
IL89377A0 (en) Substituted imidazolinones and imidazolinethiones,their preparation and pharmaceutical compositions containing them
IL111216A0 (en) Heteroarylpiperidines, their preparation and pharmaceutical compositions containing them
IL104424A0 (en) Pyrrolylbenzodiazepinones,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment